A novelly synthesized phenanthroline derivative is a promising DNA-damaging anticancer agent inhibiting G1/S checkpoint transition and inducing cell apoptosis in cancer cells
- 21 November 2015
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 77 (1) , 169-180
Abstract
Purpose The study mainly aimed to determine the biological function of a novelly synthesized phenanthroimidazole derivative, named L233, and to explore its potential mechanisms. Methods Cell survival was examined using the MTT assays, and the DNA-damaging role of L233 was explored using the comet assay. Moreover, the western blotting assays and immunofluorescence assays were used to detect DNA damage biomarkers. Afterward, the flow cytometry was used to assess the effects of L233 on cell cycle distribution. As for the detection of cell apoptosis upon L233 treatment, the Hoechst 33342 staining, flow cytometry, and western blotting assays were all put into practice. Results We find that L233 inhibits tumor cell growth more efficiently and safely than cisplatin. Moreover, it is a DNA-damaging agent, interrupting the cell cycle G1/S checkpoint transition and inducing cell apoptosis by not only activating ATM/CHK1 signaling pathway, but also targeting CHK1 to reduce the expression of RAP80 and PARP-1 to compromise the DNA damage repair in tumor cells. Conclusions In summary, L233 is a promising anticancer drug for the development of novel chemotherapies in the future.Keywords
Funding Information
- Shanghai Young Science and Technology Talents Sailing Program (15YF1409300)
- National Natural Science Foundation of China (81272292, 81071524, 81171778, 81371913, 81472624,)
This publication has 36 references indexed in Scilit:
- Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumoursCancer Chemotherapy and Pharmacology, 2013
- A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancerBreast Cancer Research and Treatment, 2012
- Evaluation of DNA Single and Double Strand Breaks in Women with Cervical Neoplasia Based on Alkaline and Neutral Comet Assay TechniquesJournal of Biomedicine and Biotechnology, 2012
- Regulatory networks integrating cell cycle control with DNA damage checkpoints and double-strand break repairPhilosophical Transactions of the Royal Society B: Biological Sciences, 2011
- USP10 Regulates p53 Localization and Stability by Deubiquitinating p53Cell, 2010
- Caspase-7: A protease involved in apoptosis and inflammationThe International Journal of Biochemistry & Cell Biology, 2010
- The Rap80-BRCC36 de-ubiquitinating enzyme complex antagonizes RNF8-Ubc13-dependent ubiquitination events at DNA double strand breaksProceedings of the National Academy of Sciences, 2009
- RNF8 Ubiquitylates Histones at DNA Double-Strand Breaks and Promotes Assembly of Repair ProteinsCell, 2007
- The anti-apoptotic factor Che-1/AATF links transcriptional regulation, cell cycle control, and DNA damage responseCell Division, 2007
- Emerging cancer therapeutic opportunities target DNA-repair systemsTrends in Pharmacological Sciences, 2006